CRTX

Cortexyme Stock Price

59.85
-4.35 (-6.78%)
Upgrade to Real-Time
Regular Market
59.85

Low
26.6612

52 Week Range

High
66.13

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Cortexyme Inc CRTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-4.35 -6.78% 59.85 12:57:36
Open Price Low Price High Price Close Price Prev Close
64.53 59.43 64.9814 64.20
Bid Price Ask Price Spread News
59.67 60.06 0.39 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,570 96,034 $ 61.29 $ 5,885,957 - 26.6612 - 66.13
Last Trade Time Type Quantity Stock Price Currency
12:57:36 3 $ 60.0001 USD

Period:

Draw Mode:

Cortexyme Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.77B 29.59M 17.00M $ - $ - -2.63 -22.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -6.43k 2.60%

more financials information »

Cortexyme News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week53.4766.1352.6961.17195,8336.3811.93%
1 Month55.7366.1350.1457.01191,9314.127.39%
3 Months39.9866.1333.1748.95204,71819.8749.7%
6 Months31.8166.1329.5141.00267,04428.0488.15%
1 Year42.5766.1326.661240.65211,60417.2840.59%
3 Years20.0073.8419.3541.54164,23239.85199.25%
5 Years20.0073.8419.3541.54164,23239.85199.25%

Cortexyme Description

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis or P. gingivalis, and its secreted toxic virulence factor proteases called gingipains. The company operates in only one reportable segment that is developing and commercializing therapeutics.


Your Recent History
NASDAQ
CRTX
Cortexyme
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.